Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient.

The European respiratory journal - 1 Jul 2015

Kempf Emmanuelle, Planchard David, Le Chevalier Thierry, Soria Jean-Charles

Abstract excerpt

No abstract is available from the source.

Topics

Angiogenesis Inhibitors
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Clinical Trials as Topic
Disease-Free Survival
ErbB Receptors
Erlotinib Hydrochloride
Exons
Female
Gefitinib
Gene Deletion
Humans
Lung Neoplasms
Middle Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Mutation

Neoplasm Metastasis

Protein-Tyrosine Kinases

Quinazolines

Source

Identifiers

PMID: 25882801
DOI: 10.1183/09031936.00017315

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient.PMID 25882801Read ↗

Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.Semantic proximity Read ↗

Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.Semantic proximity Read ↗

Is It Time to Implement Adjuvant Targeted Therapy in EGFR-Mutant Non-Small-Cell Lung Cancer?Semantic proximity Read ↗

Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort.Semantic proximity Read ↗

Miliary EGFR mutated non-small cell lung cancer.Semantic proximity Read ↗

Long-term survival in a patient with advanced non-smoking lung adenocarcinoma and no EGFR mutation after comprehensive therapy with EGFR-TKI-based therapy: A case report.Semantic proximity Read ↗

Impact of EGFR Mutations on Survival and Clinical Response in Non-Small Cell Lung Cancer in a Tertiary Care Hospital.Semantic proximity Read ↗

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.Semantic proximity Read ↗

Exploring the Next Frontier in Non-Small-Cell Lung Cancer With High MET and Mutated Epidermal Growth Factor Receptor.Semantic proximity Read ↗

Adjuvant Targeted Therapy for Patients With Epidermal Growth Factor Receptor-Mutant Lung Cancer.Semantic proximity Read ↗

Incorporation of EGFR mutation status into M descriptor of new TNM classification influences survival curves in non-small cell lung cancer patients.Semantic proximity Read ↗

Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium ExperienceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.